Sign In
Buy APRE
$0.762
-0.0022 (-0.288%)
At Close: Jun 03, 2026
Aprea Therapeutics, Inc. (NASDAQ:APRE) Shares Sold by Walleye Capital LLC
01:54pm, Sunday, 14'th Nov 2021 Dakota Financial News
Walleye Capital LLC decreased its holdings in shares of Aprea Therapeutics, Inc. (NASDAQ:APRE) by 16.5% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 98,931 shares of the companys stock after selling 19,545 shares during the period. Walleye Capital LLC owned approximately 0.47% of []
Aprea Therapeutics Stock Jumps After Eprenetapopt Combo Data Presentation At ESMO
08:39am, Tuesday, 21'st Sep 2021
Aprea Therapeutics Inc (NASDAQ: APRE) presented data at the European Society of Medical Oncology (ESMO) Congress 2021 from its Phase 1/2 trial in advanced solid tumors. The trial is evaluating the
Aprea Therapeutics Presents Data From Phase 1/2 Trial of Eprenetapopt (APR-246) in Advanced Solid Tumors at ESMO Congress 2021
04:15pm, Monday, 20'th Sep 2021
BOSTON, Sept. 20, 2021 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc. (Nasdaq: APRE), a biopharmaceutical company focused on developing and commercializing novel cancer therapeutics that reactivate the
Is the Options Market Predicting a Spike in Aprea Therapeutics (APRE) Stock?
09:57am, Monday, 20'th Sep 2021
Investors need to pay close attention to Aprea Therapeutics (APRE) stock based on the movements in the options market lately.
APRE Stock: Why It Increased Today
09:30am, Monday, 20'th Sep 2021
The stock price of Aprea Therapeutics Inc (NASDAQ: APRE) is trading higher today. This is why it happened.
Best Penny Stocks To Buy? 5 To Watch This Week With Biotech Catalysts
10:25am, Sunday, 19'th Sep 2021
Penny stocks with important dates to know this week. The post Best Penny Stocks To Buy?
Aprea Therapeutics Reports Second Quarter 2021 Financial Results and Provides Update on Business Operations
04:15pm, Thursday, 12'th Aug 2021
BOSTON, Aug. 12, 2021 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc. (Nasdaq: APRE), a biopharmaceutical company focused on developing and commercializing novel cancer therapeutics that reactivate the
Aprea Therapeutics Drops After FDA Clinical Hold On Another Blood Cancer Study
06:37am, Thursday, 12'th Aug 2021
After instituting a partial clinical hold on Aprea Therapeutics Inc's (NASDAQ: APRE) myeloid malignancies program, the FDA has placed a clinical hold on Aprea's lymphoid malignancy study. The
Aprea Therapeutics Announces Clinical Hold on Lymphoid Malignancy Program
06:00am, Thursday, 12'th Aug 2021
BOSTON, Aug. 12, 2021 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc. (Nasdaq: APRE), a biopharmaceutical company focused on developing and commercializing novel cancer therapeutics that reactivate mutan
Aprea Therapeutics Stock Drops On FDA Clinical Hold On Eprenetapopt Myeloid Malignancy Trials
08:14am, Friday, 06'th Aug 2021
The FDA has instituted a partial clinical hold on Aprea Therapeutics Inc's (NASDAQ: APRE) clinical trials of eprenetapopt (APR-246) combined with azacitidine in its myeloid malignancy programs.
Aprea Therapeutics Announces a Partial Clinical Hold on Myeloid Malignancy Programs
05:00pm, Thursday, 05'th Aug 2021
BOSTON, Aug. 05, 2021 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc. (Nasdaq: APRE), a biopharmaceutical company focused on developing and commercializing novel cancer therapeutics that reactivate mutan
Implied Volatility Surging for Aprea (APRE) Stock Options
09:47am, Friday, 18'th Jun 2021
Investors need to pay close attention to Aprea (APRE) stock based on the movements in the options market lately.
Aprea (APRE) Stock Rises as Leukemia Triplet Meets Study Goal
10:32am, Thursday, 17'th Jun 2021
Aprea (APRE) announces that treatment with a combination regimen of its pipeline candidate, eprenetapopt, achieves 37% complete response rate in acute myeloid leukemia patients.
STOCKHOLM, SWEDEN – June 17, 2021. Karolinska Development AB (Nasdaq Stockholm: KDEV) announces today that its portfolio company Aprea Therapeutics has reported positive outcomes in an ongoing Phase
Best Biotech Penny Stocks to Buy? Here's 3 That Are Well Funded
03:49pm, Wednesday, 16'th Jun 2021
Looking for well-funded biotech penny stocks? Check these 3 small-caps out The post Best Biotech Penny Stocks to Buy?
